A novel preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs
J. J. Sutherland, D. Yonchev, A. Fekete, L. Urban
The paper introduces a database of drug-target-adverse reaction associations using in vitro assays, revealing novel off-target activities and challenging existing ADR links.
bioRxiv · Jan 31, 2023Pharmacology & Toxicology